| Factor Information | |
|---|---|
| Data ID | 2474 |
| Factor | patient age |
| Description | Mean follow-up after HTx was 7.8 ± 6.8 years. Survival at 1 month was 37.7% in Group I, 85.8% in Group II, 96.8% in Group II and 98.4% in Group IV and was significantly worse in younger recipients. |
| Biomarker | NA |
| Classification | E1 (physiological factor - age) |
| Association | |
|---|---|
| Application | Treatment |
| Objective | correlation between age and mortality |
| p Value | 0.04 |
| Conclusion | We demonstrated that heart transplantation for patients with CHD can be performed with the expectation of excellent results. Previous procedures, including the Fontan operation, do not reduce survival. Mortality is related to preoperative patient condition. We advocate early referral of complex CHD patients for transplant assessment and for inclusion in waiting lists before the detrimental effects of end-stage failure manifest themselves. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 603 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | UVH/TA/DILV, PA/DILV, PS/DILV/UVH, TGA/HLHS/DOLV/UAVC/PA, IVS/TOF/PA, VSD/TGA/TGA/AVC/EA/SD/MD/AD, CoA/CoA, VSD/TAPVR/CACA/TOF, AVC/MAD |
| Reference | |
|---|---|
| PMID | 22733841 |
| Year | 2013 |
| Title | Is heart transplantation for complex congenital heart disease a good option? A 25-year single centre experience. |
| Sample | ||
|---|---|---|
| Population | All | |
| Source | N/A | |
| Region | Bergamo, Italy | |
| Method | N/A | |
| Race | European | |
| Disease History | Fontan failure | |
| Treatment History | Heart transplantation | |
| Group | <1 year(Treatment) | 1-10 years; 20-18 years; >18 years(Control) |
| Number | 8 | 20 (1-10 years); 24 (20-18 years); 33 (>18 years) |
| Age | < 1years | 1-10 years (Group II); 20-18 years (Group Ⅲ); >18 years (Group IV ) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | Survival: 37.7% | Survival: 85.8% (1-10 years); 96.8% (20-18 years); 98.4% (>18 years) |
